Variant report

Variant	esv3486412
Chromosome Location	chr12:123186029-123195050
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:61)
CpG islands
(count:366)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:61 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr12:123192855-123193151	K562	blood:	n/a	n/a
2	CEBPB	chr12:123187833-123188233	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr12:123192198-123192210	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr12:123192177-123192277	Hela-S3	cervix:	n/a	chr12:123192205-123192216
5	CEBPB	chr12:123187794-123188089	HepG2	liver:	n/a	n/a
6	CEBPB	chr12:123187869-123188146	A549	lung:	n/a	n/a
7	CEBPB	chr12:123192060-123192294	HepG2	liver:	n/a	chr12:123192205-123192216
8	CEBPB	chr12:123194984-123195338	MCF-7	breast:	n/a	n/a
9	CEBPB	chr12:123192059-123192377	IMR90	lung:	n/a	chr12:123192205-123192216
10	CEBPB	chr12:123192061-123192396	A549	lung:	n/a	chr12:123192205-123192216
11	E2F4	chr12:123187896-123188134	MCF10A-Er-Src	breast:	n/a	n/a
12	EBF1	chr12:123187949-123188264	GM12878	blood:	n/a	n/a
13	EBF1	chr12:123187913-123188259	GM12878	blood:	n/a	n/a
14	EP300	chr12:123187789-123188123	HepG2	liver:	n/a	n/a
15	FOS	chr12:123187821-123188180	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr12:123187570-123188311	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr12:123187706-123188305	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr12:123187796-123188158	MCF10A-Er-Src	breast:	n/a	n/a
19	FOSL2	chr12:123193878-123194221	HepG2	liver:	n/a	n/a
20	FOXA1	chr12:123187806-123188302	HepG2	liver:	n/a	n/a
21	FOXA1	chr12:123187829-123188220	HepG2	liver:	n/a	n/a
22	FOXA2	chr12:123187936-123188118	HepG2	liver:	n/a	n/a
23	GATA2	chr12:123194868-123195095	SH-SY5Y	brain:	n/a	n/a
24	GATA2	chr12:123192789-123193089	K562	blood:	n/a	n/a
25	GATA3	chr12:123194897-123195387	MCF-7	breast:	n/a	n/a
26	GATA3	chr12:123193377-123193611	T-47D	breast:	n/a	n/a
27	GATA3	chr12:123194991-123195209	MCF-7	breast:	n/a	n/a
28	GATA3	chr12:123194628-123195408	MCF-7	breast:	n/a	n/a
29	HDAC2	chr12:123194915-123195367	MCF-7	breast:	n/a	n/a
30	HEY1	chr12:123187714-123188013	HepG2	liver:	n/a	n/a
31	JUND	chr12:123194874-123195301	MCF-7	breast:	n/a	n/a
32	MYC	chr12:123187750-123188250	MCF10A-Er-Src	breast:	n/a	n/a
33	MYC	chr12:123187728-123188305	MCF10A-Er-Src	breast:	n/a	n/a
34	NR2F2	chr12:123194900-123195374	MCF-7	breast:	n/a	n/a
35	NR2F2	chr12:123194844-123195369	MCF-7	breast:	n/a	n/a
36	NR2F2	chr12:123192809-123193203	K562	blood:	n/a	n/a
37	POLR2A	chr12:123187757-123187873	HepG2	liver:	n/a	n/a
38	POLR2A	chr12:123193902-123193996	MCF-7	breast:	n/a	n/a
39	POLR2A	chr12:123185972-123186119	MCF10A-Er-Src	breast:	n/a	n/a
40	POLR2A	chr12:123187704-123188015	Hela-S3	cervix:	n/a	n/a
41	POLR2A	chr12:123187462-123188263	MCF10A-Er-Src	breast:	n/a	n/a
42	POLR2A	chr12:123194004-123194048	MCF-7	breast:	n/a	n/a
43	POLR2A	chr12:123193640-123193770	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr12:123187655-123188092	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr12:123186413-123186760	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr12:123186895-123186998	HUVEC	blood vessel:	n/a	n/a
47	POU2F2	chr12:123187839-123188275	GM12878	blood:	n/a	n/a
48	POU2F2	chr12:123188001-123188214	GM12878	blood:	n/a	n/a
49	SIN3AK20	chr12:123194769-123195325	MCF-7	breast:	n/a	n/a
50	SP1	chr12:123193704-123194211	HepG2	liver:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:123187073-123187123	ECC-1	luminal epithelium:	n/a
2	chr12:123187073-123187123	HNPCEpiC	eye:	n/a
3	chr12:123189236-123189286	U87	brain:	n/a
4	chr12:123187529-123187579	HRE	kidney:	n/a
5	chr12:123187073-123187123	GM12891	blood:	n/a
6	chr12:123189236-123189286	NHDF-neo	bronchial:	n/a
7	chr12:123187474-123187524	AG04450	lung:	fetal
8	chr12:123189236-123189286	GM12892	blood:	n/a
9	chr12:123189236-123189286	SK-N-MC	brain:	n/a
10	chr12:123187073-123187123	AG10803	skin:	n/a
11	chr12:123187073-123187123	GM12892	blood:	n/a
12	chr12:123187474-123187524	AG04449	skin:	fetal
13	chr12:123187529-123187579	AoSMC	blood vessel:	n/a
14	chr12:123187474-123187524	SKMC	muscle:	n/a
15	chr12:123187529-123187579	H1-hESC	embryonic stem cell:	embryo
16	chr12:123188078-123188128	SK-N-SH_RA	brain:	n/a
17	chr12:123187529-123187579	AG10803	skin:	n/a
18	chr12:123187529-123187579	A549	lung:	n/a
19	chr12:123189256-123189306	NH-A	brain:	n/a
20	chr12:123189256-123189306	AG09309	skin:	n/a
21	chr12:123188078-123188128	Hela-S3	cervix:	n/a
22	chr12:123188078-123188128	CMK	blood:	n/a
23	chr12:123187474-123187524	HUVEC	blood vessel:	n/a
24	chr12:123189236-123189286	NH-A	brain:	n/a
25	chr12:123189236-123189286	ovcar-3	ovarian:	n/a
26	chr12:123187073-123187123	A549	lung:	n/a
27	chr12:123187073-123187123	Hela-S3	cervix:	n/a
28	chr12:123189236-123189286	A549	lung:	n/a
29	chr12:123187529-123187579	HCF	heart:	n/a
30	chr12:123189236-123189286	NT2-D1	testis:	n/a
31	chr12:123188078-123188128	H1-hESC	embryonic stem cell:	embryo
32	chr12:123189236-123189286	HCF	heart:	n/a
33	chr12:123189256-123189306	SK-N-SH	brain:	n/a
34	chr12:123187073-123187123	BE2_C	brain:	n/a
35	chr12:123189236-123189286	LNCaP	prostate:	n/a
36	chr12:123187474-123187524	NB4	blood:	n/a
37	chr12:123187073-123187123	NT2-D1	testis:	n/a
38	chr12:123187529-123187579	HepG2	liver:	n/a
39	chr12:123189236-123189286	AG09319	gingival:	n/a
40	chr12:123187529-123187579	HAEpiC	amniotic membrane:	n/a
41	chr12:123188078-123188128	BE2_C	brain:	n/a
42	chr12:123189256-123189306	HRPEpiC	eye:	n/a
43	chr12:123187073-123187123	HL-60	blood:	n/a
44	chr12:123189256-123189306	HEK293	kidney:	embryo
45	chr12:123187474-123187524	T-47D	breast:	n/a
46	chr12:123189236-123189286	Jurkat	blood:	n/a
47	chr12:123187073-123187123	HCT-116	colon:	n/a
48	chr12:123187529-123187579	HCT-116	colon:	n/a
49	chr12:123188078-123188128	LNCaP	prostate:	n/a
50	chr12:123189236-123189286	MCF-7	breast:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:123186486..123188573-chr12:123199930..123201817,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DENR-2	chr12:123185843-123186416	NONHSAT031529

No data

Variant related genes	Relation type
ENSG00000256249	TF binding region
HCAR2	TF binding region
ENSG00000256249	CpG island
HCAR2	CpG island
ENSG00000255398	chromatin interactions

Extended variants
information (count: 520 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:520 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs147030932	chr12:123186064-123186065	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
2	rs147676678	chr12:123186131-123186132	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
3	rs190136170	chr12:123186153-123186154	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
4	rs569782642	chr12:123186154-123186155	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
5	rs584219	chr12:123186168-123186169	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
6	rs555718018	chr12:123186178-123186179	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
7	rs2549	chr12:123186215-123186216	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs566466824	chr12:123186228-123186229	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
9	rs541032921	chr12:123186229-123186230	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
10	rs146556314	chr12:123186240-123186241	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs577659688	chr12:123186273-123186274	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs544812148	chr12:123186279-123186280	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs563885648	chr12:123186280-123186281	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs397840439	chr12:123186284-123186285	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs377202232	chr12:123186294-123186295	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs542878618	chr12:123186303-123186304	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs561254378	chr12:123186305-123186306	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs528420708	chr12:123186311-123186312	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs492752	chr12:123186365-123186366	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs546584512	chr12:123186374-123186375	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs492699	chr12:123186381-123186382	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs149401193	chr12:123186401-123186402	Enhancers Weak transcription Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs370733933	chr12:123186429-123186430	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs369029402	chr12:123186436-123186437	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs582856	chr12:123186458-123186459	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs538058928	chr12:123186488-123186489	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs549254377	chr12:123186492-123186493	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs67140489	chr12:123186506-123186507	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs567565510	chr12:123186513-123186514	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs375378061	chr12:123186524-123186525	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs582452	chr12:123186539-123186540	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs552918434	chr12:123186555-123186556	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs187079814	chr12:123186587-123186588	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs579935	chr12:123186596-123186597	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs76270247	chr12:123186610-123186611	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs79685171	chr12:123186611-123186612	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs202220470	chr12:123186692-123186693	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs143443624	chr12:123186699-123186700	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs200807592	chr12:123186708-123186709	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs200735597	chr12:123186720-123186721	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs470939	chr12:123186730-123186731	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs369377442	chr12:123186734-123186735	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs63475561	chr12:123186741-123186742	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs200253923	chr12:123186744-123186745	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs201579375	chr12:123186747-123186748	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs199966560	chr12:123186748-123186749	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs202231409	chr12:123186749-123186750	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs200856181	chr12:123186757-123186758	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs200247476	chr12:123186769-123186770	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs201426235	chr12:123186773-123186774	Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17133270	CNVD
Breast cancer	17603634	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Cryptorchidism	21048976	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Neuroblastoma	18923191	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Beckwith-Wiedemann syndrome	20648245	CNVD
Developmental delay	21457577	CNVD
dysmorphic	21457577	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chordoma	18071362	CNVD

Chromatin state (count:76 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:123166600-123187800	Weak transcription	A549	lung
2	chr12:123174000-123199800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr12:123184000-123188800	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr12:123185200-123187200	Active TSS	Esophagus	oesophagus
5	chr12:123185400-123186200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr12:123185400-123186800	Active TSS	Primary hematopoietic stem cells	blood
7	chr12:123185400-123188200	Active TSS	Primary B cells from cord blood	blood
8	chr12:123185800-123186200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr12:123185800-123186200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr12:123185800-123186400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
11	chr12:123185800-123186400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr12:123185800-123187000	Flanking Active TSS	Adipose Nuclei	Adipose
13	chr12:123186000-123186200	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr12:123186000-123186200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr12:123186000-123186400	Enhancers	NHLF	lung
16	chr12:123186000-123187400	Weak transcription	HMEC	breast
17	chr12:123186000-123188000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr12:123186000-123188000	Enhancers	Placenta	Placenta
19	chr12:123186000-123188200	Enhancers	NHEK	skin
20	chr12:123186000-123188600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
21	chr12:123186000-123188600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
22	chr12:123186200-123186400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr12:123186200-123186400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr12:123186200-123186600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr12:123186200-123186600	Enhancers	Fetal Stomach	stomach
26	chr12:123186200-123186800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr12:123186200-123186800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr12:123186200-123186800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr12:123186200-123186800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr12:123186400-123186600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr12:123186400-123187400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr12:123186600-123186800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr12:123186600-123186800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr12:123186800-123187000	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr12:123186800-123187400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr12:123186800-123187800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr12:123186800-123188000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr12:123187000-123187200	Enhancers	Adipose Nuclei	Adipose
39	chr12:123187000-123188000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr12:123187200-123187600	Flanking Active TSS	Esophagus	oesophagus
41	chr12:123187200-123187800	Flanking Active TSS	Adipose Nuclei	Adipose
42	chr12:123187400-123187600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr12:123187400-123187800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
44	chr12:123187400-123187800	Enhancers	Spleen	Spleen
45	chr12:123187400-123188000	Enhancers	HMEC	breast
46	chr12:123187400-123188200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr12:123187400-123188600	Enhancers	Hela-S3	cervix
48	chr12:123187600-123187800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr12:123187600-123187800	Active TSS	Esophagus	oesophagus
50	chr12:123187600-123187800	Enhancers	Fetal Thymus	thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links